Effects of omalizumab combined with budesonide formoterol on clinical efficacy, pulmonary function, immune function, and adverse reactions in children with moderate and severe allergic asthma
CONCLUSION: The combination of omalizumab with budesonide formoterol for treating moderate and severe allergic asthma in children demonstrated promising clinical efficacy and improved their pulmonary and immune functions, leading to more rational asthma control. The combined regimen demonstrated satisfactory clinical safety and deserved clinical promotion.PMID:37422796 | DOI:10.15586/aei.v51i4.926 (Source: Allergologia et Immunopathologia)
Source: Allergologia et Immunopathologia - July 9, 2023 Category: Allergy & Immunology Authors: Fuzhe Chen Lei Liang Fang Fang Chu Changlong Lu Chongyu Xu Source Type: research
Effect of budesonide formoterol combined with tiotropium bromide on pulmonary function and inflammatory factors in patients with asthma-COPD overlap syndrome
CONCLUSION: The combination of budesonide formoterol to tiotropium bromide in treating asthma-COPD overlap syndrome may significantly improve pulmonary function, endothelial function, and immune status of patients and encourage the recovery of serum lipid peroxidation injury; therefore, this may deserve widespread adoption and application.PMID:37422789 | DOI:10.15586/aei.v51i4.876 (Source: Allergologia et Immunopathologia)
Source: Allergologia et Immunopathologia - July 9, 2023 Category: Allergy & Immunology Authors: Ting Jiang Pengfei Li Yang Wang Source Type: research
Effects of omalizumab combined with budesonide formoterol on clinical efficacy, pulmonary function, immune function, and adverse reactions in children with moderate and severe allergic asthma
CONCLUSION: The combination of omalizumab with budesonide formoterol for treating moderate and severe allergic asthma in children demonstrated promising clinical efficacy and improved their pulmonary and immune functions, leading to more rational asthma control. The combined regimen demonstrated satisfactory clinical safety and deserved clinical promotion.PMID:37422796 | DOI:10.15586/aei.v51i4.926 (Source: Allergologia et Immunopathologia)
Source: Allergologia et Immunopathologia - July 9, 2023 Category: Allergy & Immunology Authors: Fuzhe Chen Lei Liang Fang Fang Chu Changlong Lu Chongyu Xu Source Type: research
Effect of budesonide formoterol combined with tiotropium bromide on pulmonary function and inflammatory factors in patients with asthma-COPD overlap syndrome
CONCLUSION: The combination of budesonide formoterol to tiotropium bromide in treating asthma-COPD overlap syndrome may significantly improve pulmonary function, endothelial function, and immune status of patients and encourage the recovery of serum lipid peroxidation injury; therefore, this may deserve widespread adoption and application.PMID:37422789 | DOI:10.15586/aei.v51i4.876 (Source: Allergologia et Immunopathologia)
Source: Allergologia et Immunopathologia - July 9, 2023 Category: Allergy & Immunology Authors: Ting Jiang Pengfei Li Yang Wang Source Type: research
Effects of omalizumab combined with budesonide formoterol on clinical efficacy, pulmonary function, immune function, and adverse reactions in children with moderate and severe allergic asthma
CONCLUSION: The combination of omalizumab with budesonide formoterol for treating moderate and severe allergic asthma in children demonstrated promising clinical efficacy and improved their pulmonary and immune functions, leading to more rational asthma control. The combined regimen demonstrated satisfactory clinical safety and deserved clinical promotion.PMID:37422796 | DOI:10.15586/aei.v51i4.926 (Source: Allergologia et Immunopathologia)
Source: Allergologia et Immunopathologia - July 9, 2023 Category: Allergy & Immunology Authors: Fuzhe Chen Lei Liang Fang Fang Chu Changlong Lu Chongyu Xu Source Type: research
Effect of budesonide formoterol combined with tiotropium bromide on pulmonary function and inflammatory factors in patients with asthma-COPD overlap syndrome
CONCLUSION: The combination of budesonide formoterol to tiotropium bromide in treating asthma-COPD overlap syndrome may significantly improve pulmonary function, endothelial function, and immune status of patients and encourage the recovery of serum lipid peroxidation injury; therefore, this may deserve widespread adoption and application.PMID:37422789 | DOI:10.15586/aei.v51i4.876 (Source: Allergologia et Immunopathologia)
Source: Allergologia et Immunopathologia - July 9, 2023 Category: Allergy & Immunology Authors: Ting Jiang Pengfei Li Yang Wang Source Type: research
Effects of omalizumab combined with budesonide formoterol on clinical efficacy, pulmonary function, immune function, and adverse reactions in children with moderate and severe allergic asthma
CONCLUSION: The combination of omalizumab with budesonide formoterol for treating moderate and severe allergic asthma in children demonstrated promising clinical efficacy and improved their pulmonary and immune functions, leading to more rational asthma control. The combined regimen demonstrated satisfactory clinical safety and deserved clinical promotion.PMID:37422796 | DOI:10.15586/aei.v51i4.926 (Source: Allergologia et Immunopathologia)
Source: Allergologia et Immunopathologia - July 9, 2023 Category: Allergy & Immunology Authors: Fuzhe Chen Lei Liang Fang Fang Chu Changlong Lu Chongyu Xu Source Type: research
Effect of budesonide formoterol combined with tiotropium bromide on pulmonary function and inflammatory factors in patients with asthma-COPD overlap syndrome
CONCLUSION: The combination of budesonide formoterol to tiotropium bromide in treating asthma-COPD overlap syndrome may significantly improve pulmonary function, endothelial function, and immune status of patients and encourage the recovery of serum lipid peroxidation injury; therefore, this may deserve widespread adoption and application.PMID:37422789 | DOI:10.15586/aei.v51i4.876 (Source: Allergologia et Immunopathologia)
Source: Allergologia et Immunopathologia - July 9, 2023 Category: Allergy & Immunology Authors: Ting Jiang Pengfei Li Yang Wang Source Type: research
Effects of omalizumab combined with budesonide formoterol on clinical efficacy, pulmonary function, immune function, and adverse reactions in children with moderate and severe allergic asthma
CONCLUSION: The combination of omalizumab with budesonide formoterol for treating moderate and severe allergic asthma in children demonstrated promising clinical efficacy and improved their pulmonary and immune functions, leading to more rational asthma control. The combined regimen demonstrated satisfactory clinical safety and deserved clinical promotion.PMID:37422796 | DOI:10.15586/aei.v51i4.926 (Source: Allergologia et Immunopathologia)
Source: Allergologia et Immunopathologia - July 9, 2023 Category: Allergy & Immunology Authors: Fuzhe Chen Lei Liang Fang Fang Chu Changlong Lu Chongyu Xu Source Type: research
Effect of budesonide formoterol combined with tiotropium bromide on pulmonary function and inflammatory factors in patients with asthma-COPD overlap syndrome
CONCLUSION: The combination of budesonide formoterol to tiotropium bromide in treating asthma-COPD overlap syndrome may significantly improve pulmonary function, endothelial function, and immune status of patients and encourage the recovery of serum lipid peroxidation injury; therefore, this may deserve widespread adoption and application.PMID:37422789 | DOI:10.15586/aei.v51i4.876 (Source: Allergologia et Immunopathologia)
Source: Allergologia et Immunopathologia - July 9, 2023 Category: Allergy & Immunology Authors: Ting Jiang Pengfei Li Yang Wang Source Type: research
Effects of omalizumab combined with budesonide formoterol on clinical efficacy, pulmonary function, immune function, and adverse reactions in children with moderate and severe allergic asthma
CONCLUSION: The combination of omalizumab with budesonide formoterol for treating moderate and severe allergic asthma in children demonstrated promising clinical efficacy and improved their pulmonary and immune functions, leading to more rational asthma control. The combined regimen demonstrated satisfactory clinical safety and deserved clinical promotion.PMID:37422796 | DOI:10.15586/aei.v51i4.926 (Source: Allergologia et Immunopathologia)
Source: Allergologia et Immunopathologia - July 9, 2023 Category: Allergy & Immunology Authors: Fuzhe Chen Lei Liang Fang Fang Chu Changlong Lu Chongyu Xu Source Type: research
Effect of budesonide formoterol combined with tiotropium bromide on pulmonary function and inflammatory factors in patients with asthma-COPD overlap syndrome
CONCLUSION: The combination of budesonide formoterol to tiotropium bromide in treating asthma-COPD overlap syndrome may significantly improve pulmonary function, endothelial function, and immune status of patients and encourage the recovery of serum lipid peroxidation injury; therefore, this may deserve widespread adoption and application.PMID:37422789 | DOI:10.15586/aei.v51i4.876 (Source: Allergologia et Immunopathologia)
Source: Allergologia et Immunopathologia - July 9, 2023 Category: Allergy & Immunology Authors: Ting Jiang Pengfei Li Yang Wang Source Type: research
Effects of omalizumab combined with budesonide formoterol on clinical efficacy, pulmonary function, immune function, and adverse reactions in children with moderate and severe allergic asthma
CONCLUSION: The combination of omalizumab with budesonide formoterol for treating moderate and severe allergic asthma in children demonstrated promising clinical efficacy and improved their pulmonary and immune functions, leading to more rational asthma control. The combined regimen demonstrated satisfactory clinical safety and deserved clinical promotion.PMID:37422796 | DOI:10.15586/aei.v51i4.926 (Source: Allergologia et Immunopathologia)
Source: Allergologia et Immunopathologia - July 9, 2023 Category: Allergy & Immunology Authors: Fuzhe Chen Lei Liang Fang Fang Chu Changlong Lu Chongyu Xu Source Type: research
Effect of budesonide formoterol combined with tiotropium bromide on pulmonary function and inflammatory factors in patients with asthma-COPD overlap syndrome
CONCLUSION: The combination of budesonide formoterol to tiotropium bromide in treating asthma-COPD overlap syndrome may significantly improve pulmonary function, endothelial function, and immune status of patients and encourage the recovery of serum lipid peroxidation injury; therefore, this may deserve widespread adoption and application.PMID:37422789 | DOI:10.15586/aei.v51i4.876 (Source: Allergologia et Immunopathologia)
Source: Allergologia et Immunopathologia - July 9, 2023 Category: Allergy & Immunology Authors: Ting Jiang Pengfei Li Yang Wang Source Type: research
Effect of budesonide formoterol combined with tiotropium bromide on pulmonary function and inflammatory factors in patients with asthma-COPD overlap syndrome
CONCLUSION: The combination of budesonide formoterol to tiotropium bromide in treating asthma-COPD overlap syndrome may significantly improve pulmonary function, endothelial function, and immune status of patients and encourage the recovery of serum lipid peroxidation injury; therefore, this may deserve widespread adoption and application.PMID:37422789 | DOI:10.15586/aei.v51i4.876 (Source: Allergologia et Immunopathologia)
Source: Allergologia et Immunopathologia - July 9, 2023 Category: Allergy & Immunology Authors: Ting Jiang Pengfei Li Yang Wang Source Type: research
